Abiomed
ABMD
#1098
Rank
NZ$27.77 B
Marketcap
$615.87
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Earnings for Abiomed (ABMD)

Earnings in 2022 (TTM): NZ$0.55 B

According to Abiomed's latest financial reports the company's current earnings (TTM) are NZ$0.55 B. In 2021 the company made an earning of NZ$0.30 B a decrease over its 2020 earnings that were of NZ$0.41 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Abiomed from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) NZ$0.55 B79.78%
2021 NZ$0.30 B-25.49%
2020 NZ$0.41 B-19.62%
2019 NZ$0.51 B48.14%
2018 NZ$0.34 B51%
2017 NZ$0.22 B71.85%
2016 NZ$0.13 B41.79%
2015 NZ$93.72 M187.69%
2014 NZ$32.57 M126.26%
2013 NZ$14.39 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.60 B 9.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.46 B 528.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$52.39 M-109.50%๐Ÿ‡บ๐Ÿ‡ธ USA